1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Non-surgical Skin Tightening Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Non-surgical Skin Tightening Market, by Type of Treatment
8.1.1. Ultrasound Therapy
8.1.1.1. Market Revenue and Forecast
8.1.2. Radiofrequency Therapy
8.1.2.1. Market Revenue and Forecast
8.1.3. Laser Therapy
8.1.3.1. Market Revenue and Forecast
8.1.4. Microneedling
8.1.4.1. Market Revenue and Forecast
8.1.5. Infrared Therapy
8.1.5.1. Market Revenue and Forecast
8.1.6. Cryolipolysis
8.1.7.1. Market Revenue and Forecast
9.1. Non-surgical Skin Tightening Market, by Technology
9.1.1. HIFU (High-Intensity Focused Ultrasound)
9.1.1.1. Market Revenue and Forecast
9.1.2. Laser Technology
9.1.2.1. Market Revenue and Forecast
9.1.3. Radiofrequency Technology
9.1.3.1. Market Revenue and Forecast
9.1.4. Microneedling Technology
9.1.4.1. Market Revenue and Forecast
10.1. Non-surgical Skin Tightening Market, by End-User
10.1.1. Beauty Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Dermatology Clinics
10.1.2.1. Market Revenue and Forecast
10.1.3. Cosmetic Surgeons
10.1.3.1. Market Revenue and Forecast
10.1.4. Spas & Wellness Centers
10.1.4.1. Market Revenue and Forecast
11.1. Non-surgical Skin Tightening Market, by Age Group
11.1.1. Millennials (18–34 years)
11.1.1.1. Market Revenue and Forecast
11.1.2. Gen X (35–54 years)
11.1.2.1. Market Revenue and Forecast
11.1.3. Baby Boomers (55 years and above)
11.1.3.1. Market Revenue and Forecast
12.1. Non-surgical Skin Tightening Market, by Gender
12.1.1. Male
12.1.1.1. Market Revenue and Forecast
12.1.2. Female
12.1.2.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type of Treatment
13.1.2. Market Revenue and Forecast, by Technology
13.1.3. Market Revenue and Forecast, by End-User
13.1.4. Market Revenue and Forecast, by Age Group
13.1.5. Market Revenue and Forecast, by Gender
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type of Treatment
13.1.6.2. Market Revenue and Forecast, by Technology
13.1.6.3. Market Revenue and Forecast, by End-User
13.1.6.4. Market Revenue and Forecast, by Age Group
13.1.6.5. Market Revenue and Forecast, by Gender
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Type of Treatment
13.1.7.2. Market Revenue and Forecast, by Technology
13.1.7.3. Market Revenue and Forecast, by End-User
13.1.7.4. Market Revenue and Forecast, by Age Group
13.1.7.5. Market Revenue and Forecast, by Gender
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type of Treatment
13.2.2. Market Revenue and Forecast, by Technology
13.2.3. Market Revenue and Forecast, by End-User
13.2.4. Market Revenue and Forecast, by Age Group
13.2.5. Market Revenue and Forecast, by Gender
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type of Treatment
13.2.6.2. Market Revenue and Forecast, by Technology
13.2.6.3. Market Revenue and Forecast, by End-User
13.2.7. Market Revenue and Forecast, by Age Group
13.2.8. Market Revenue and Forecast, by Gender
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type of Treatment
13.2.9.2. Market Revenue and Forecast, by Technology
13.2.9.3. Market Revenue and Forecast, by End-User
13.2.10. Market Revenue and Forecast, by Age Group
13.2.11. Market Revenue and Forecast, by Gender
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type of Treatment
13.2.12.2. Market Revenue and Forecast, by Technology
13.2.12.3. Market Revenue and Forecast, by End-User
13.2.12.4. Market Revenue and Forecast, by Age Group
13.2.13. Market Revenue and Forecast, by Gender
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type of Treatment
13.2.14.2. Market Revenue and Forecast, by Technology
13.2.14.3. Market Revenue and Forecast, by End-User
13.2.14.4. Market Revenue and Forecast, by Age Group
13.2.15. Market Revenue and Forecast, by Gender
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type of Treatment
13.3.2. Market Revenue and Forecast, by Technology
13.3.3. Market Revenue and Forecast, by End-User
13.3.4. Market Revenue and Forecast, by Age Group
13.3.5. Market Revenue and Forecast, by Gender
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type of Treatment
13.3.6.2. Market Revenue and Forecast, by Technology
13.3.6.3. Market Revenue and Forecast, by End-User
13.3.6.4. Market Revenue and Forecast, by Age Group
13.3.7. Market Revenue and Forecast, by Gender
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type of Treatment
13.3.8.2. Market Revenue and Forecast, by Technology
13.3.8.3. Market Revenue and Forecast, by End-User
13.3.8.4. Market Revenue and Forecast, by Age Group
13.3.9. Market Revenue and Forecast, by Gender
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type of Treatment
13.3.10.2. Market Revenue and Forecast, by Technology
13.3.10.3. Market Revenue and Forecast, by End-User
13.3.10.4. Market Revenue and Forecast, by Age Group
13.3.10.5. Market Revenue and Forecast, by Gender
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type of Treatment
13.3.11.2. Market Revenue and Forecast, by Technology
13.3.11.3. Market Revenue and Forecast, by End-User
13.3.11.4. Market Revenue and Forecast, by Age Group
13.3.11.5. Market Revenue and Forecast, by Gender
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type of Treatment
13.4.2. Market Revenue and Forecast, by Technology
13.4.3. Market Revenue and Forecast, by End-User
13.4.4. Market Revenue and Forecast, by Age Group
13.4.5. Market Revenue and Forecast, by Gender
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type of Treatment
13.4.6.2. Market Revenue and Forecast, by Technology
13.4.6.3. Market Revenue and Forecast, by End-User
13.4.6.4. Market Revenue and Forecast, by Age Group
13.4.7. Market Revenue and Forecast, by Gender
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type of Treatment
13.4.8.2. Market Revenue and Forecast, by Technology
13.4.8.3. Market Revenue and Forecast, by End-User
13.4.8.4. Market Revenue and Forecast, by Age Group
13.4.9. Market Revenue and Forecast, by Gender
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type of Treatment
13.4.10.2. Market Revenue and Forecast, by Technology
13.4.10.3. Market Revenue and Forecast, by End-User
13.4.10.4. Market Revenue and Forecast, by Age Group
13.4.10.5. Market Revenue and Forecast, by Gender
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type of Treatment
13.4.11.2. Market Revenue and Forecast, by Technology
13.4.11.3. Market Revenue and Forecast, by End-User
13.4.11.4. Market Revenue and Forecast, by Age Group
13.4.11.5. Market Revenue and Forecast, by Gender
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type of Treatment
13.5.2. Market Revenue and Forecast, by Technology
13.5.3. Market Revenue and Forecast, by End-User
13.5.4. Market Revenue and Forecast, by Age Group
13.5.5. Market Revenue and Forecast, by Gender
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type of Treatment
13.5.6.2. Market Revenue and Forecast, by Technology
13.5.6.3. Market Revenue and Forecast, by End-User
13.5.6.4. Market Revenue and Forecast, by Age Group
13.5.7. Market Revenue and Forecast, by Gender
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type of Treatment
13.5.8.2. Market Revenue and Forecast, by Technology
13.5.8.3. Market Revenue and Forecast, by End-User
13.5.8.4. Market Revenue and Forecast, by Age Group
13.5.8.5. Market Revenue and Forecast, by Gender
14.1. Allergan (AbbVie)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cutera
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Lumenis
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Syneron Candela
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. BTL Industries
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Venus Concept
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Sciton
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Hologic
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Fotona
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Alma Lasers
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
